Cutler Group LP Xenon Pharmaceuticals Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$30.79 - $39.82 $3,079 - $3,982	100 New	100 $3,000
Q4 2021 Jan 18, 2022	SELL	$15.6 - $35.4 $20,170 - $45,772	-1,293 Reduced 68.3%	600 $18,000
Q3 2021 Oct 26, 2021	BUY	$14.86 - $19.45 $14,860 - $19,450	1,000 Added 111.98%	1,893 $28,000
Q2 2021 Jul 19, 2021	BUY	$16.81 - $20.0 $1,563 - $1,860	93 Added 11.63%	893 $16,000
Q3 2020 Oct 27, 2020	SELL	$10.82 - $13.35 $1,828 - $2,256	-169 Reduced 17.44%	800 $8,000
Q4 2019 Feb 06, 2020	BUY	$8.11 - $14.65 $7,858 - $14,195	969 New	969 $12,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.